![Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases | FinancialContent Business Page Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases | FinancialContent Business Page](https://cdn.benzinga.com/files/images/story/2023/10/18/ardx.png?width=1200&height=800&fit=crop)
Ardelyx Inc Stock News | ARDX Company Stock News and Press Releases | FinancialContent Business Page
![Ardelyx on X: "Press Release: FDA Grants Appeal for Ardelyx's XPHOZAH® (tenapanor) Read more here: https://t.co/drMd3jYvKl https://t.co/DYmGNsa9Nt" / X Ardelyx on X: "Press Release: FDA Grants Appeal for Ardelyx's XPHOZAH® (tenapanor) Read more here: https://t.co/drMd3jYvKl https://t.co/DYmGNsa9Nt" / X](https://pbs.twimg.com/media/FlJPTbXXwAEHD0o.jpg:large)
Ardelyx on X: "Press Release: FDA Grants Appeal for Ardelyx's XPHOZAH® (tenapanor) Read more here: https://t.co/drMd3jYvKl https://t.co/DYmGNsa9Nt" / X
Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial | PDF | Chronic Kidney Disease | Therapy
![ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Ardelyx Stockholders and Encourages Investors to Contact the Firm | Business Wire ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Ardelyx Stockholders and Encourages Investors to Contact the Firm | Business Wire](https://mms.businesswire.com/media/20210721005984/en/538768/23/BES_Mark.jpg)
ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Ardelyx Stockholders and Encourages Investors to Contact the Firm | Business Wire
![And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%. | Internet | Biotech Stock Review And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%. | Internet | Biotech Stock Review](https://internetstockreview.com/wp-content/uploads/2023/04/chart-4.jpg)